MeiraGTx Holdings (MGTX) Current Leases (2017 - 2025)
MeiraGTx Holdings' (MGTX) quarterly Current Leases came in at $2.9 million in Q4 2025, down 29.66% YoY from $4.1 million in Q4 2024, and up 15.19% on a QoQ basis from $2.5 million in Q3 2025.
MeiraGTx Holdings (MGTX) Current Leases (2017 - 2025) Analysis & Trends
MeiraGTx Holdings (MGTX) has 9 years of Current Leases data on file, last reported at $2.9 million in Q4 2025.
- Quarterly Current Leases fell 29.66% year-over-year to $2.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.9 million (down 29.66% YoY) and the FY2025 annual result came in at $2.9 million, down 29.66% from the prior year.
- Current Leases advanced to $2.9 million in Q4 2025, from $2.5 million in the prior quarter.
- In the past five years, Current Leases ranged from a high of $4.2 million in Q2 2024 to a low of $2.5 million in Q3 2025.
- A 5-year average of $3.6 million and a median of $3.6 million in 2022 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2021 — Current Leases jumped 55.01% — and 2025, when it plunged 40.83%.
- Tracing MGTX's Current Leases over 5 years: stood at $3.4 million in 2021, then grew by 15.12% to $3.9 million in 2022, then increased by 7.96% to $4.2 million in 2023, then declined by 3.34% to $4.1 million in 2024, then declined by 29.66% to $2.9 million in 2025.
- The last three Current Leases figures came in at $2.9 million (Q4 2025), $2.5 million (Q3 2025), and $2.6 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 11.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 16.75 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 21.95 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 2.24 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 45.93 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.27 Mn |
| 10 | MeiraGTx Holdings | 1.10 Bn | 1.03 Bn | - | 2.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.85 Mn |
| Sep 30, 2025 | 2.48 Mn |
| Jun 30, 2025 | 2.65 Mn |
| Mar 31, 2025 | 3.30 Mn |
| Dec 31, 2024 | 4.05 Mn |
| Sep 30, 2024 | 4.18 Mn |
| Jun 30, 2024 | 4.21 Mn |
| Mar 31, 2024 | 4.19 Mn |
| Dec 31, 2023 | 4.19 Mn |
| Sep 30, 2023 | 4.09 Mn |
| Jun 30, 2023 | 4.13 Mn |
| Mar 31, 2023 | 4.02 Mn |
| Dec 31, 2022 | 3.88 Mn |
| Sep 30, 2022 | 3.66 Mn |
| Jun 30, 2022 | 3.63 Mn |
| Mar 31, 2022 | 3.63 Mn |
| Dec 31, 2021 | 3.37 Mn |
| Sep 30, 2021 | 3.28 Mn |
| Jun 30, 2021 | 3.17 Mn |
| Mar 31, 2021 | 2.77 Mn |